腹部手术生长抑素类药物规范应用的研究进展  

Research advances of standardized application of somatostatin after abdominal operation

作　　者：张太平[1] 陈超武[2] 李非[3] 张群[4] 李洪奇 Zhang Taiping;Chen Chaowu;Li Fei;Zhang Qun;Li Hongqi(Department of General Surgery,Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100730,China;Department of Gastrointestinal Surgery,Hunan Provincial People′s Hospital,Changsha 410005,China;Department of General Surgery,Clinical Center for Acute Pancreatitis,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Medical Insurance Administration,Beijing Hospital,Beijing 100730,China;Beijing Dacheng Law Offices,Beijing 100020,China)

机构地区：[1]中国医学科学院北京协和医学院北京协和医院基本外科,北京100730 [2]湖南省人民医院胃肠外科,长沙410005 [3]首都医科大学宣武医院普通外科、首都医科大学急性胰腺炎临床诊疗与研究中心,北京100053 [4]北京医院医疗保险管理处,北京100730 [5]北京大成律师事务所,北京100020

出　　处：《中华消化外科杂志》2024年第5期676-679,共4页Chinese Journal of Digestive Surgery

摘　　要：腹部手术作为临床常见的手术类型,术后治疗和康复一直是外科医师高度关注的重点。生长抑素类药物常用于腹部手术后出血、门静脉高压症出血、急性胰腺炎等并发症的预防性治疗。临床实践中,生长抑素类药物的规范应用尚存在许多问题和挑战。本文汇集国内消化外科领域著名专家及其团队、医保专家及律师,结合各中心经验,从不同角度探讨腹部手术后治疗和康复的重要意义以及生长抑素类药物的应用策略。张太平教授精简凝练地讲解消化道瘘的发生率及其危害,指出“如何能够短时间内把瘘愈合”是主要康复目标且治疗方式主要为综合治疗。陈超武教授全面介绍临床实践中几个典型病例的诊断与治疗过程,分享其团队丰富临床经验,并提出反思性问题。李非教授从实际病例入手,重点讲解十二指肠瘘,包括经内镜逆行术后并发症引起的瘘,特别强调Stanford分型,以及不同分型的治疗方法。张群女士解读国家医保政策,强调医保基金监管的重要性,分享医疗机构自主管理的相关问题。李洪奇律师从政策导向、实践案例等方面,就合理用药全面提出建议。Abdominal surgery as a common type of clinical surgery,postoperative treatment and rehabilitation has always been the focus of surgeons.Somatostatin drugs are commonly used for postoperative bleeding,portal hypertension bleeding,and prophylactic treatment of complications such as acute pancreatitis.However,the standardized application of somatostatin still faces numerous challenges in clinical practice.The famous experts and their teams in the field of digestive surgery,medical insurance expert and lawyer,combined with the experience of their respective centers,under the new national medical insurance policy,explore the significance of treatment and rehabilitation after abdominal surgery and the application strategy of somatostatin drugs from different angles.Professor Zhang Taiping succinctly explained the incidence and harm of gastrointestinal fistula,pointing out that"how to heal the fistula in a short time"is the main rehabilitation goal and the treatment is mainly comprehensive treatment.Professor Chen Chaowu comprehen-sively introduces diagnostic and treatment processes for several representative cases encountered in clinical practice while sharing his team′s rich clinical experience and posing reflective questions.Professor Li Fei starts with practical cases,focusing on duodenal fistula,including fistula caused by complications after endoscopic retrograde cholangiopancreatography,with special emphasis on Stanford classification and different types of treatment.Ms.Zhang Qun interprets national medical insurance policies.She emphasizes the significance of supervising medical insurance funds and shares experiences related to issues regarding autonomous management by healthcare institutions.Lawyer Li Hongqi provides comprehensive suggestions on rational use of drug based on policy guidance and practical cases.

关 键 词：腹部手术 生长抑素 规范应用 消化外科 研究进展 

分 类 号：R61[医药卫生—外科学]